Human Longevity Competitors and Similar CompaniesClear all
BenevolentAI's competitors and similar companies include Astellas Gene Therapies.
 BenevolentAI BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences. |  Astellas Gene Therapies Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases. | |
Founding Date | Founding Date 2013 | Founding Date 2013 |
Type | Type Private | Type Subsidiary |
Tags | ||
Locations | Locations London, GB HQ Babraham, GB | Locations San Francisco, US HQ |
Employees | Employees 180 | Employees 4061% decrease |
Financial | ||
Net income | Net income (€63.3m) (FY, 2023) | Net income ($128.8m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 305m | Total funding raised $ 180m |
For sources of this data, please see the company profile
View Company Profiles
Astellas Gene Therapies
HQ
San Francisco, US
Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
View company